# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-26-055689
Filing Date
2026-05-05
Accepted
2026-05-05 16:41:24
Documents
77
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | tmb-20260331x10q.htm iXBRL | 10-Q | 1347161
2 | EX-31.1 | tmb-20260331xex31d1.htm | EX-31.1 | 13971
3 | EX-32.1 | tmb-20260331xex32d1.htm | EX-32.1 | 5936
4 | GRAPHIC | tmb-20260331x10q001.jpg | GRAPHIC | 40637
| Complete submission text file | 0001104659-26-055689.txt |  | 7005260

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | tmb-20260331.xsd | EX-101.SCH | 61734
6 | EX-101.CAL | tmb-20260331_cal.xml | EX-101.CAL | 56119
7 | EX-101.DEF | tmb-20260331_def.xml | EX-101.DEF | 191261
8 | EX-101.LAB | tmb-20260331_lab.xml | EX-101.LAB | 487487
9 | EX-101.PRE | tmb-20260331_pre.xml | EX-101.PRE | 347500
81 | EXTRACTED XBRL INSTANCE DOCUMENT | tmb-20260331x10q_htm.xml | XML | 1166487

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 26944034
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)